Adaptimmune Therapeutics Plc Current ratio
Что обозначает Current ratio в Adaptimmune Therapeutics Plc?
Current ratio Adaptimmune Therapeutics Plc является 3.09
Какое определение для Current ratio?
Коэффициент текущей ликвидности - это коэффициент ликвидности, который измеряет, достаточно ли у компании ресурсов для выполнения своих краткосрочных обязательств.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio компаний в Health Care сектор на NASDAQ по сравнению с Adaptimmune Therapeutics Plc
Что делает Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Компании с current ratio похож на Adaptimmune Therapeutics Plc
- PT Aneka Tambang Tbk имеет Current ratio из 3.09
- The a2 Milk имеет Current ratio из 3.09
- Zevia PBC имеет Current ratio из 3.09
- PF имеет Current ratio из 3.09
- Pipeline Engineering имеет Current ratio из 3.09
- Secoo Ltd имеет Current ratio из 3.09
- Adaptimmune Therapeutics Plc имеет Current ratio из 3.09
- Larsen & Toubro Infotech имеет Current ratio из 3.09
- Beauce Gold Fields имеет Current ratio из 3.09
- KEI Industries имеет Current ratio из 3.09
- Sohu.com имеет Current ratio из 3.09
- The Peria Karamalai Tea and Produce имеет Current ratio из 3.09
- Graphite India имеет Current ratio из 3.09